KL and hepatocellular carcinoma: The changes in metabolic pathways mediated by dysregulated Kla modifications in GI tumors were consistent with a previous conclusion in HCC.[34] In addition to metabolic alterations, multiple Kla sites in proteins involved in RNA regulation, genome stability, and proteasome are also dysregulated in GI cancer.